|Bid||2.7800 x 21500|
|Ask||2.8000 x 39400|
|Day's Range||2.6600 - 2.8700|
|52 Week Range||1.9500 - 28.8500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Every investor in Clover Health Investments, Corp. ( NASDAQ:CLOV ) should be aware of the most powerful shareholder...
Clover Health Investments’ (NASDAQ:CLOV) earnings continue being negative although some operating numbers seem to offer hope of a better stock price in the future for CLOV stock. For instance, in February the company announced that its 2022 revenues were expected to be more than $3 billion; this would be largely thanks to a forecast 90% yearly growth in the number of lives under management. Considering that the company reported that there was an increase of almost 300% year over year in the numb
Dr. Carolyn McClanahan, a CFP at Life Planning Partners, joins Yahoo Finance Live to break down health care and Medicare options that investors should consider when planning for retirement.